Signature Estate & Investment Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Signature Estate & Investment Advisors's LLY Position: Q2 2026 in Review
Signature Estate & Investment Advisors increased its Eli Lilly (LLY) stake by 0.53% in Q2 2026, buying an estimated $310K and bringing the position to 57,559 shares worth $69M. The position accounts for 1.24% of the portfolio, ranked #22.
Signature Estate & Investment Advisors first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. The position peaked at $78M in Q4 2025. 3,039 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Signature Estate & Investment Advisors held 57,559 shares of Eli Lilly worth $69M as of Q2 2026.
- Signature Estate & Investment Advisors bought 303 Eli Lilly shares in Q2 2026, an estimated $310K.
- Eli Lilly made up 1.24% of Signature Estate & Investment Advisors's portfolio in Q2 2026, its #22 holding.
- Signature Estate & Investment Advisors first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
- Signature Estate & Investment Advisors's Eli Lilly position peaked at $78M in Q4 2025.
- 3,039 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Signature Estate & Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.